164 related articles for article (PubMed ID: 1964579)
1. Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle.
Endoh M; Satoh H; Norota I; Hirano K
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1127-34. PubMed ID: 1964579
[TBL] [Abstract][Full Text] [Related]
2. Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle.
Satoh H; Endoh M
Jpn J Pharmacol; 1990 Feb; 52(2):215-24. PubMed ID: 2156096
[TBL] [Abstract][Full Text] [Related]
3. Subcellular mechanism of the positive inotropic effect of a new quinolinone derivative OPC-8490 on the dog ventricular myocardium.
Endoh M; Satoh H; Norota I; Hirano K; Hosokawa T
Heart Vessels; 1991; 6(3):158-67. PubMed ID: 1655692
[TBL] [Abstract][Full Text] [Related]
4. Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 Cl in canine ventricular myocardium.
Endoh M; Shibasaki T; Satoh H; Norota I; Ishihata A
J Cardiovasc Pharmacol; 1991 Mar; 17(3):365-75. PubMed ID: 1711596
[TBL] [Abstract][Full Text] [Related]
5. Involvement of cyclic AMP in the positive inotropic effect of OPC-8212, a new cardiotonic agent, on the canine ventricular muscle.
Yanagisawa T; Endoh M; Taira N
Jpn J Pharmacol; 1984 Nov; 36(3):379-88. PubMed ID: 6097725
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular responses to a newly developed cardiotonic agent, ZSY-39 [4-methyl-5-(4-pyridinyl)-thiazole-2-carboxyamide] in dog cross-circulated atrial and ventricular preparations.
Chiba S; Furukawa Y; Saegusa K; Ogiwara Y; Takeda M
Jpn Heart J; 1987 Mar; 28(2):253-60. PubMed ID: 3599412
[TBL] [Abstract][Full Text] [Related]
7. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
Endoh M; Yamashita S; Taira N
J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063
[TBL] [Abstract][Full Text] [Related]
8. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
Endoh M; Yanagisawa T; Taira N; Blinks JR
Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of effects of UK-1745, a novel cardiotonic agent with beta-adrenoceptor-blocking action, in aequorin-loaded canine right ventricular muscle.
Sawada H; Endoh M
J Mol Cell Cardiol; 1999 May; 31(5):1047-62. PubMed ID: 10336843
[TBL] [Abstract][Full Text] [Related]
10. Effects of a novel cardiotonic agent (+-)-6-[3-(3,4-dimethoxybenzylamino)-2-hydroxypropoxy]-2(1H)-quinolino ne (OPC-18790) on contractile force, cyclic AMP level, and aequorin light transients in dog ventricular myocardium.
Endoh M; Kawabata Y; Katano Y; Norota I
J Cardiovasc Pharmacol; 1994 May; 23(5):723-30. PubMed ID: 7521454
[TBL] [Abstract][Full Text] [Related]
11. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?
Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N
J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754
[TBL] [Abstract][Full Text] [Related]
12. Effects of a novel cardiotonic agent, Org 9731, on force and aequorin light transients in intact ventricular myocardium of the dog: involvement of a cyclic AMP-mediated mechanism and myofibrillar responsiveness to Ca2+ ions.
Kawabata Y; Endoh M
J Card Fail; 1995 Mar; 1(2):143-53. PubMed ID: 9420644
[TBL] [Abstract][Full Text] [Related]
13. Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism.
Endoh M
Basic Res Cardiol; 1989; 84 Suppl 1():69-83. PubMed ID: 2554874
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043.
Endoh M; Yanagisawa T; Morita T; Taira N
J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507
[TBL] [Abstract][Full Text] [Related]
15. Decreased inotropic but relatively preserved relaxation response to cyclic adenosine monophosphate-dependent agents in myopathic human myocardium.
Gutstein DE; Flemmal K; Bruce E; Travers KE; Gwathmey JK; Ransil BJ; Markis JE; Grossman W; Morgan JP
J Card Fail; 1996 Dec; 2(4):285-92. PubMed ID: 8989643
[TBL] [Abstract][Full Text] [Related]
16. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
Katano Y; Endoh M
J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
[TBL] [Abstract][Full Text] [Related]
17. Cholera toxin-induced changes in force of contraction and cyclic AMP levels in canine ventricular myocardium: inhibition by carbachol.
Endoh M; Maruyama M; Yanagisawa T
Life Sci; 1984 Dec; 35(24):2397-406. PubMed ID: 6096655
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic receptor stimulation and cyclic AMP-dependent effects in guinea-pig ventricular myocardium.
Schmied R; Korth M
Br J Pharmacol; 1990 Feb; 99(2):401-7. PubMed ID: 1691677
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of cyclic AMP and contractile responses to isoprenaline: effects of a dihydropyridine derivative, nicardipine (YC-93), on canine ventricular muscle.
Endoh M; Yanagisawa T; Taira N
Eur J Pharmacol; 1980 Oct; 67(2-3):225-33. PubMed ID: 6257529
[TBL] [Abstract][Full Text] [Related]
20. Cardiotonic activity of 5-methyl-6-(4-pyridyl)-2H-1,4-thiazin-3(4H)-one hydrochloride (ZSY-27).
Yoshioka K; Hino M; Yoshimura A; Yamazaki H; Takase M; Ono H
J Pharmacobiodyn; 1988 Nov; 11(11):715-21. PubMed ID: 3236203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
